Clinical Trial Update: Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low molecular weight heparin vs dabigatran in patients with stable coronary artery disease to assess effects on platelet aggregation; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED